title: Dynamic principle for designing antagonistic/agonistic molecules for EphA4 receptor, the only known ALS modifier.
abstract: Additional to involvement in diverse physiological and pathological processes such as axon regeneration, synaptic plasticity, and cancers, EphA4 receptor has been recently identified as the only amyotrophic lateral sclerosis (ALS) modifier. Previously, we found that two small molecules bind the same EphA4 channel at almost equivalent affinities but mysteriously trigger opposite signaling outputs: one activated but another inhibited. Here, we determined the solution structure of the 181-residue EphA4 LBD, which represents the first for 16 Eph receptors. Further NMR dynamic studies deciphered that the agonistic and antagonistic effects of two small molecules are dynamically driven, which are achieved by oppositely modulating EphA4 dynamics. Consequently, in design of drugs to target EphA4, the dynamic requirement also needs to be satisfied in addition to the classic criteria. For example, to increase the survival of ALS patients by inhibiting EphA4, the drugs must enhance, or at least not suppress, the EphA4 dynamics.
authors.affiliation: Department of Biological Sciences, Faculty of Science, National University of Singapore , 10 Kent Ridge Crescent, Singapore 119260, Singapore.
authors.forename: Haina
authors.initials: H
authors.lastname: Qin
authors.forename: Liang-Zhong
authors.initials: LZ
authors.lastname: Lim
authors.forename: Jianxing
authors.initials: J
authors.lastname: Song
mesh_terms: D000690:Amyotrophic Lateral Sclerosis / Q000378:metabolism*; D006801:Humans; D009682:Magnetic Resonance Spectroscopy; D008958:Models, Molecular; D011487:Protein Conformation; D017434:Protein Structure, Tertiary; D036122:Receptor, EphA4 / Q000819:agonists* / Q000037:antagonists & inhibitors*
chemical_list: D036122:Receptor, EphA4